China Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The China Diabetes Devices Market Report is Segmented Into Management Devices (Insulin Pumps, Insulin Syringes, Infusion Sets, Insulin Cartridges, Disposable Pens, And Insulin Jet Injectors) and Monitoring Devices (Self-Monitoring Blood Glucose and Continuous Glucose Monitoring). The Market Provides the Value (in USD) and (in Units) for the Above-Mentioned Segments.

China Diabetes Devices Market Size

China Diabetes Devices Market Summary
View Global Report

China Diabetes Devices Market Analysis

The China Diabetes Devices Market size is estimated at USD 7.78 billion in 2025, and is expected to reach USD 9.77 billion by 2030, at a CAGR of 4.66% during the forecast period (2025-2030).

China has witnessed a significant rise in the prevalence of diabetes in recent decades, posing a major public health challenge for the nation. This surge in diabetes cases can be primarily attributed to factors such as rapid urbanization, sedentary lifestyles, unhealthy dietary habits, and an aging population. According to data from the International Diabetes Federation (IDF), China has the highest number of adults diagnosed with diabetes worldwide, surpassing 100 million individuals.

As the diabetes epidemic continues to unfold, there has been a corresponding increase in the demand for diabetes devices. These devices play a crucial role in managing diabetes by equipping individuals with tools to monitor their blood glucose levels, administer insulin, and track their overall health. Glucose meters, insulin pumps, continuous glucose monitoring (CGM) systems, and insulin pens are among the commonly used devices in diabetes management.

The growing population of individuals with diabetes in China has stimulated innovation and investment in the diabetes devices market. Both domestic and international manufacturers are capitalizing on this escalating demand by introducing advanced technologies and expanding their range of products. Chinese companies are leveraging their expertise in manufacturing and research to develop cost-effective devices that cater to the specific needs of the local population.

Furthermore, the Chinese government has acknowledged the pressing need to tackle the diabetes crisis and has introduced a range of measures to enhance diabetes management and prevention. These initiatives involve raising public awareness, advocating for healthy lifestyles, improving healthcare access, and providing subsidies for diabetes devices to low-income individuals.

In conclusion, the expanding diabetes population in China is propelling the growth of the diabetes devices market, emphasizing innovation, affordability, and accessibility. Dealing with the diabetes epidemic necessitates a holistic approach that covers prevention, early detection, and effective management strategies. By investing in diabetes prevention and treatment, China can alleviate the disease's impact and enhance the health and well-being of its populace.

China Diabetes Devices Industry Overview

The new technologies in diabetes devices, like continuous glucose monitoring, have increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system rather than merely offering a boost to the continuous glucose monitoring device market.

China Diabetes Devices Market Leaders

  1. Abbott

  2. Medtronics

  3. Roche

  4. Becton, Dickinson & Company

  5. Dexcom

  6. *Disclaimer: Major Players sorted in no particular order
China Diabetes Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

China Diabetes Devices Market News

  • February 2023: The MiniMed670G BLE, developed by Medtronic MiniMed, has received approval from the China NMPA. This advanced product includes an insulin pump kit, transmitter kit, and glucose sensor. It incorporates two key technologies: a hybrid closed-loop algorithm for auto mode and electrochemical impedance spectroscopy technology to monitor sensor status, ensuring accurate glucose readings.
  • June 2022: LifeScan revealed a significant development as the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) published Real World Evidence showcasing improved glycemic control in individuals with diabetes. This positive outcome is attributed to the utilization of a Bluetooth-connected Blood Glucose Meter in conjunction with a Mobile Diabetes Management Application. The OneTouch Reveal mobile app, paired with the OneTouch Verio Reflect meter via Bluetooth wireless technology, emerges as a pivotal tool supporting enhanced glycemic control for those managing diabetes.

China Diabetes Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Restraints
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products and Services
    • 4.3.5 Intensity of Competitive Rivalry

5. Market Segmentation

  • 5.1 Monitoring Devices
    • 5.1.1 Self-monitoring Blood Glucose Devices
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous Glucose Monitoring
    • 5.1.2.1 Sensors
    • 5.1.2.2 Receivers (Receivers and Transmitters)
  • 5.2 Management Devices
    • 5.2.1 Insulin Delivery Devices
    • 5.2.1.1 Insulin Pump
    • 5.2.1.1.1 Insulin Pump Device
    • 5.2.1.1.2 Insulin Pump Reservoir
    • 5.2.1.1.3 Infusion Set
    • 5.2.1.2 Insulin Syringes
    • 5.2.1.3 Insulin Disposable Pens
    • 5.2.1.4 Insulin Cartridges in Reusable pens
    • 5.2.1.5 Insulin Jet Injectors

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Roche
    • 7.1.2 Abbott
    • 7.1.3 Johnson & Johnson
    • 7.1.4 Novo Nordisk
    • 7.1.5 Becton, Dickinson & Company
    • 7.1.6 Medtronic
    • 7.1.7 SinoCare
    • 7.1.8 Sanofi
    • 7.1.9 ARKRAY Inc.
    • 7.1.10 Ascensia Diabetes Care
    • 7.1.11 ACON Laboratories Inc.
    • 7.1.12 Eli Lilly
    • 7.1.13 Bionime Corporation
    • 7.1.14 Rossmax International Ltd.
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products andĀ Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

China Diabetes Devices Industry Segmentation

Utilizing continuous glucose monitoring (CGM), diabetes devices effectively track fluctuations in blood sugar levels and dynamically adjust insulin administration to prevent extremes of high or low blood glucose. While the introduction of automated insulin delivery systems (AIDs) has mitigated the psychological burden of managing diabetes, ongoing research aims to further enhance these technologies. Insulin doses are meticulously calculated by an insulin pen based on parameters prescribed by your healthcare provider. The China diabetes devices market is segmented into management devices and monitoring devices. The report offers the value (in USD) and volume (in units) for the above segments.

Monitoring Devices Self-monitoring Blood Glucose Devices Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Receivers (Receivers and Transmitters)
Management Devices Insulin Delivery Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Insulin Disposable Pens
Insulin Cartridges in Reusable pens
Insulin Jet Injectors
Need A Different Region or Segment?
Customize Now

China Diabetes Devices Market Research Faqs

How big is the China Diabetes Devices Market?

The China Diabetes Devices Market size is expected to reach USD 7.78 billion in 2025 and grow at a CAGR of 4.66% to reach USD 9.77 billion by 2030.

What is the current China Diabetes Devices Market size?

In 2025, the China Diabetes Devices Market size is expected to reach USD 7.78 billion.

Who are the key players in China Diabetes Devices Market?

Abbott, Medtronics, Roche, Becton, Dickinson & Company and Dexcom are the major companies operating in the China Diabetes Devices Market.

What years does this China Diabetes Devices Market cover, and what was the market size in 2024?

In 2024, the China Diabetes Devices Market size was estimated at USD 7.42 billion. The report covers the China Diabetes Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Diabetes Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

China Diabetes Devices Industry Report

Statistics for the 2025 China Diabetes Devices market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. China Diabetes Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

China Diabetes Devices Market Report Snapshots

Compare market size and growth of China Diabetes Devices Market with other markets in Healthcare Industry

China Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)